Issues‎ > ‎vol7no2‎ > ‎


Expression of β-catenin in Minor Salivary Glands Adjacent to Oral Squamous Cell Carcinoma

Ban F. Ibraheem*, Dena N. Mohammad*, Marwa A. Hamied*

*Department of Oral Diagnosis, College of Dentistry, Sulaimani University, Sulaimani, Iraq.

Submitted: 09/03/2020; Accepted: 25/07/2020; Published 01/12/2020



Objective: This study aims to evaluate the expression pattern, localization, and stain intensity of β-catenin in minor salivary glands adjacent to surgically excised oral squamous cell carcinoma (OSCC).          

Methods: A retrospective study was held with 16 samples of formalin-fixed paraffin-embedded blocks with minor salivary glands adjacent to OSCC. Sections were stained and evaluated immunohistochemically
with β-catenin. The staining expression was assessed according to cellular localization, stain intensity, and, lastly, the pattern of stain distribution throughout acini.
Statistical analysis was performed using SPSS version 24.0 software for Windows, and data analyzed by Fisher's exact test. P-value <0.05 was considered as statistically significant.

Results: All minor salivary glands in the studied sample showed β-catenin staining with different expression in their functional units, as all had ductal and myoepithelial cells staining with a predominant cytoplasmic
localization. While the mucous acini showed β- catenin expression in 10 cases (62.5%), this marker was significantly less frequently detected in serous acini of two cases of poorly differentiated OSCC (p= .008).
A highly significant relation was found between the β-catenin cellular localization and stain distribution pattern in mucous and serous acini.

Conclusions: β-catenin had altered cytoplasmic expression in all of the minor salivary glands adjacent to OSCC. Furthermore, the diffuse pattern of distribution throughout the acini could identify the multi-patches
pathological alteration of this area. The current study clarifies that the adjacent clinically normal-appearing salivary glands could harbor genetic aberrations of their subsequent malignant transformation.


Keywords: Adjacent, β-catenin, Minor salivary gland, OSCC.                                                                                                                                                                                              Full Article - PDF                                                                                                                                                                                                                                   


1. De Paula F, Teshima THN, Hsieh R, Souza MM, Nico MMS, Lourenco SV. Overview of human salivary glands: highlights of morphology and developing processes. Anat Rec. 2017;300(7):1180-8.
2. Shah AAK, Mulla AF, Mayank M. Pathophysiology of myoepithelial cells in salivary glands. J Oral Maxillofac Pathol. 2016;20(3):480- 90.
3. Kessler AT, Bhatt AA. Review of the major and minor salivary glands, part 1: Anatomy, Infectious, and Inflammatory Processes. J Clin Imaging Sci. 2018;8(1):47.
4. Ianez RF, Buim ME, Coutinho-Camillo CM, Schultz R, Soares FA, Lourenc ̧o SV. Human salivary gland morphogenesis: myoepitheliall cell maturation assessed by immunohistochemical markers. Histopathology. 2010;57(3):410-7.
5. Chitturi RT, Veeravarmal V, Nirmal RM, Reddy BVR. Myoepithelial cells (MEC) of the salivary glands in health and tumours. J Clin Diagn Res. 2015;9(3):14-8.
6. Prakash S, Swaminathan U, Nagamalini BR, Krishnamurthy AB. Beta-catenin in disease. JOMFP. 2016;20(2):289-99.
7. Hai B, Yang Z, Millar SE, Choi YS, Taketo MM, Nagy A, et al. Wnt/β-catenin signaling regulates postnatal development and regeneration of the salivary gland. Stem Cells Dev. 2010;19(11):1793-801.
8. Chandrashekar C, Angadi PV, Krishnapillai R. Β- Catenin expression in benign and malignant salivary gland tumors. Int J Surg Pathol. 2011;19(4):433-40.
9. Ebrahimi M, Boldrup L, Wahlin YB, Coates PJ, Nylander K. Decreased expression of the p63 related proteins β-catenin, E-cadherin and EGFR in oral lichen planus. Oral Oncol. 2008;44(7):634- 8.
10. Queimado L, Lopes CS, Reis AM. WIF1 , an Inhibitor of the Wnt Pathway, is rearranged in salivary gland tumors. Genes Chromosomes Cancer. 2007;46(3):215-25.
11. Queimado L, Obeso D, Hatfield MD, Yang Y, Thompson DM, Reis AM. Dysregulation of Wnt pathway components in human salivary gland tumors. Arch Otolaryngol-Head Neck Surg. 2008;134(1):94-101.
12. Hameid M.A. β-catenin expression in perilesional area of different grades of oral squamous cell carcinoma. Sulaimani Dent J. 2016;3(1):25-9.
13. Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes CJ, Huvos AG, et al. Molecular support for field cancerization in the head and neck. Cancer. 1998;82(7):1376-80.
14. Sathiasekar AC, Mathew DG, Jaish Lal MS. Arul Prakash AA, Goma Kumar KU. Oral field cancerization and its clinical implications in the management in potentially malignant disorders. J Pharm Bioallied Sci. 2017;9(1):23-5.
15. Hakata Y, Fukui H, Sekikawa A, Yamagishi H, Ichikawa K, Tomita S, et al. Expression of β - catenin and REG I α in relation to cell proliferative ability in salivary gland tumors. Exp Ther Med. 2010;1(3)437-43.
16. Ankurgoyal, Bharat V, Mamta. Comparitive analysis of broder & bryne's grading of squamous cell carcinoma in different anatomical sites. IOSR- JRME. 2018;8(2):55-8.
17. Mohammed IJ. Expression of ubiquitin c-terminal hydrolase-L1 in minor normal salivary gland tissues in perilesional area to OSCC. Tikrit J Dent Sci. 2018;6(1):12-8.
18. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727-30.
19. Díez-Pérez R, Campo-Trapero J, Cano-Sánchez J, López-Durán M, Gonzalez-Moles MA, Bascones- Ilundain J, et al. Methylation in oral cancer and precancerous lesions (Review). Oncol Rep. 2011;25(5):1203-9.
20. Valenta T, Hausmann G, Basler K. The many faces and functions of Î 2-catenin. EMBO J. 2012;31(12):2714-36.
21. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127(3):469- 80.
22. Okuda Y, Nakano K, Suzuki K, Sugita Y, Kubo K. Maeda H. Wnt signaling as a possible promoting factor of cell differentiation in pleomorphic adenomas. Int J Med Sci. 2014;11(9):971-8.
23. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9-26.
24. Jo VY, Sholl LM, Krane JF. Distinctive patterns of CTNNB1 ( b -Catenin ) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol 2016;40(8):1143-50.
25. do Prado RF, Consolaro A, Taveira LAA. Expression of β-catenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: An immunohistochemical study. Med Oral Patol Oral Cir Bucal 2006;11(3):247-51. Vol 7(2)
26. Yamada K, Namba M, Kudeken W, Takai Y, Mori M, Tsukitani K, et al. Comparative expression of E-cadherin, α and β-catenin in salivary gland tumors. Acta Histochem Cytochem. 1999;32(4):305-13.
27. Genelhu MCLS, Gobbi H, Arantes DCB, Cardoso SV, Cassali GD. Immunolocalization of β-catenin in pleomorphic adenomas and carcinomas ex- pleomorphic adenomas of salivary glands. Appl Immunohistochem Mol Morphol. 2007;15(3):273- 8.
28. Wang R, Geng N, Zhou Y, Zhang D, Li L, Li J, et al. Aberrant Wnt - 1 / beta - catenin signaling and WIF - 1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic. Biomed Mater Eng. 2015;26(1):2145-53.
29. Hamied MA,Garib BT, Mohammad DN. β-catenin expression and its relation to Bryne's invasive grading system in oral squamous cell carcinoma. JBCD 2016;28(3):52-8.
30. Furuse C, Cury PR, Altemani A, Pinto DDS, De Araújo NS, De Araújo VC. β-catenin and E- cadherin expression in salivary gland tumors. Int J Surg Pathol. 2006;14(3):212-7.
31. Shang S, Hua F, Hu ZW. The regulation of β- catenin activity and function in cancer : therapeutic opportunities. Oncotarget. 2017;8(20):33972-89.
32. Anzai H. A histopathological and immunohistochemical study of cell adhesion factors in pleomorphic adenoma : mesenchyma- like changes of epithelial tumor cells. Oral Med Pathol. 2008;12:35-45.
33. Lee YH, Huang WC, Hsieh MS. CTNNB1 mutations in basal cell adenoma of the salivary gland. J Formos Med Assoc. 2018;117(10):894- 901.
34. Mohan M1, Jagannathan N. Oral field cancerization: an update on current concepts. Oncol Rev. 2014;8(1):244.

Creative Commons License © The Authors, published by University of Sulaimani, College of Dentistry